Sunscreens;Les cremes solaires

Annales de Dermatologie et de Venereologie

Volumn 126, Issue 4, 1999, Pages 357-363

  Leroy, D ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLBENZYLIDENE)CAMPHOR; 4 AMINOBENZOIC ACID; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; AVOBENZONE; DROMETRIZOLE TRISILOXANE; ENSULIZOLE; HOMOSALATE; OCTOCRYLENE; OXYBENZONE; PROTEIN P53; SUNSCREEN; TEREPHTHALYLIDENE DICAMPHO SULFONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL PROTECTION; CHEMICAL COMPOSITION; DRUG INDICATION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; LIGHT ABSORPTION; SPECTROSCOPY; SUN EXPOSURE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; CHEMISTRY; CLASSIFICATION; CUTANEOUS PARAMETERS; DRUG EFFECT; GEL; OINTMENT; PATIENT SELECTION; REVIEW; SKIN TUMOR; SUNBURN; TIME;

GELS; HUMANS; OINTMENTS; PATIENT SELECTION; SKIN AGING; SKIN NEOPLASMS; SUNBURN; SUNSCREENING AGENTS; TIME FACTORS;

EID: 0032973789     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Naylor MF, Farmer KC. The case for sunscreens. A review of their use in preventing actinic damage and neoplasia. Arch. Dermatol 1997;133:1146-54.
2. Amblard P, Beani JC. Est-il dangereux d'utiliser des topiques photoprotecteurs ? Ann Dermatol Venereol 1994;121:875-9.
3. Brown MW, Galley E. Testing UVA and UVB protection from microfine titanium dioxide. Cosmet Toiletries 1990;105:69-73.
4. Mitchnick MA. Zinc oxide, an old friend to the rescue. Cosmet Toiletries 1990;107:111-6.
5. Murphy GM. Sunblocks : mechanisms of action. Photodermatol Photoimmunol Photomed 1999;15:34-6.
6. Mitchnick MA, Fairhurst D, Pinnell SR. Microfine zinc oxide (Z-Cote) as a photostable UVA/UVB sunblock agent. J Am Acad Dermatol 1999;40:85-90.
7. Césarini JP, Chardon A, Binet O, Hourseau C, Grollier JF. High-protection sunscreen formulation prevents UVB-induced sunburn cell formation. Photodermatology 1989;6:20-3.
8. Applegate LA, Scaletta C, Treina G, Mascotto RE, Fourtanier A, Frenk E. Erythema induction by ultraviolet radiation points to a possible acquired defense mechanism in chronically sun-exposed human skin. Dermatology 1997;194: 41-9.
9. Chardon A, Moyal D, Hourseau C. Persistent pigment darkening as a method for the UVA protection assessment of sunscreens. In : Rougier A, Schaefer H, eds : Protection of the skin against ultraviolet radiations. Paris : John Libbey Eurotext, 1998:131-6.
10. Peak JG, Peak MJ, Sikorski RS, Jones CA. Induction of DNA-protein crosslinks in human cells by ultraviolet and visible radiations : action spectrum. Photochem Photobiol 1985;141:295-302.
11. Pujol JA, Lecha M. Photoprotection in the infrared radiation range. Photodermatol Photoimmunol Photomed 1992/1993;9:275-8.
12. Bissett DL, McBride JF. Synergistic topical photoprotection by a combination of the iron chelator 2-furildioxime and sunscreen. J Am Acad Dermatol 1996;35:546-9.
13. Arase S, Jung EG. In vitro evaluation of the photoprotective efficacy of sunscreens against DNA damage by UVB. Photodermatology 1986; 3:56-9.
14. Ley RD, Fourtanier A. Sunscreen protection against ultraviolet radiation-induced pyrimidine dimers in mouse epidermal DNA. Photochem Photobiol 1997;65:1007-11.
15. Van Praag MCG, Roza L, Boom BW, Out-Luijting C, Bergen Henegouwen JBA, Vermeer BJ, Mommaas AM. Determination of the photoprotective efficacy of a topical sunscreen against UVB-induced DNA damage in human epidermis. J Photochem Photobiol B Biol 1993;19:129-34.
16. Krekels G, Voorter C, Kuik F, Verhaegh M, Ramaekers F, Neumann M. DNA-protection by sunscreens: p53-immunostaining. Eur J Dermatol 1997;7:259-62.
17. Ananthaswamy HN, Loughlin SM, Cox P, Evans RL, Ullrich SE, Kripke ML. Sunlight and skin cancer : inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nat Med 1997;3:510-4.
18. Berne B, Pontén J, Pontén F. Decreased P53 expression in chronically sun-exposed human skin after topical photoprotection. Photodermatol Photoimmunol Photomed 1998;14: 148-53.
19. Walker SL, Young AR. Sunscreens offer the same UVB protection factors for inflammation and immunosuppression in the mouse. J Invest Dermatol 1997;108:133-8.
20. Beasley DG, Montgomery MA, Moloney SJ, Edmonds S, Roberts LK. Commercial sunscreen lotions prevent ultraviolet radiation-induced depletion of epidermal Langerhans cells in Skhi and C3H mice. Photodermatol Photoimmunol Photomed 1998;14:90-9.
21. Elmets CA, Vargas A, Oresajo C. Photoprotective effects of sunscreens in cosmetics on sunburn and Langerhans cell photodamage. Photodermatol Photoimmunol Photomed 1992; 9:113-20.
22. Serre I, Cano JP, Picot MC, Meynadier J, Meunier L. Immunosuppression induced by acute solar-simulated ultraviolet exposure in humans : prevention by a sunscreen with a sun protection factor of 15 and high UVA protection. J Am Acad Dermatol 1997;37:187-94.
23. Bissett DL, Hillebrand GG, Hannon DP. The hairless mouse as a model of skin photoaging : its use to evaluate photoprotective materials. Photodermatology 1989;6:228-33.
24. Harrison JA, Walker SL, Plastow SR, Batt MD, Hawk JLM, Young AR. Sunscreens with low sun protection factor inhibit ultraviolet B and A photoaging in the skin of the hairless albino mouse. Photodermatol Photoimmunol Photomed 1991;8:12-20.
25. Bernstein EF, Brown DB, Takeuchi T, Kong SK, Uitto J. Evaluation of sunscreens with various sun protection factors in a new transgenic mouse model of cutaneous photoaging that measures elastin promoter activation. J Am Acad Dermatol 1997;37:725-9.
26. Fourtanier A, Labat-Robert J, Kern P, Berrebi C, Gracia AM, Boyer B. In vivo evaluation of photoprotection against chronic ultraviolet-A irradiation by a new sunscreen Mexoryl® SX. Photochem Photobiol 1992;55:549-60.
27. Lavker RM, Gerberick GF, Veres D, Irwin CJ, Kaidbey KH. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol 1995;32:53-62.
28. Séite S, Moyal D, Richard S, de Rigal J, Léve̊que JL, Hourseau C, Fourtanier A. Mexoryl ® SX : a broad absorption UVA filter protects human skin from the effects of repeated suberythemal doses of UVA. J Photochem Photobiol B Biol 1998;44:69-76.
29. Bestak R, Halliday GM. Sunscreens protection from UV-promoted squamous cell carcinoma in mice chronically irradiated with doses of UV radiation insufficient to cause edema. Photochem Photobiol 1996;64:188-93.
30. Fourtanier A. Mexoryl®® SX protects against solar-simulated UVR-induced photocarcinogenesis in mice. Photochem Photobiol 1996;64: 688-93.
31. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993;329:1147-51.
32. Wulf HC, Poulsen T, Brodthagen H, HouJensen K. Sunscreens for delay of ultraviolet induction of skin tumors. J Am Acad Dermatol 1982;7:194-202.
33. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia ? Analysis of trends between 1931 and 1994. Br Med J 1996; 312:1121-5.
34. Santoro E. On photo-stability of oxybenzone. J Invest Dermatol 1998;110:95-7.
35. Rapp C, Heinsohn G, Hintze U. Raman spectroscopic studies showing the UV stability of oxybenzone. J Invest Dermatol 1998;110:97-8.
36. Fairhurst D. Surface coating and the optimization of microfine oxides in sunscreen formulations. Cosmet Toiletries 1997;112:81-8.
37. Hagedorn-Leweke U, Lippold BC. Absorption of sunscreens and other compounds through human skin in vivo : derivation of a method to predict maximum fluxes. Pharm Res 1995;12:1354-60.
38. Treffel P, Gabard B. Skin penetration and sun protection factor of ultra-violet filters from two vehicles. Pharm Res 1996;13:770-4.
39. Dromgoole SH, Maibach HI. Sunscreening agent intolerance : contact and photocontact sensitization and contact urticaria. J Am Acad Dermatol 1990;22:1068-78.
40. Szczurko C, Dompmartin A, Michel M, Moreau A, Leroy D. Photocontact allergy to oxybenzone : ten years of experience. Photodermatol Photoimmunol Photomed 1994;10:144-7.
41. Arancibia A, Borie G. Cornwell E, Medrano C. Pharmacokinetic study on the percutaneous absorption of p-aminobenzoic acid from three sunscreen preparations. Farmaco Ed. Pr. 1981; 8:357-65.
42. Hayden CGJ, Roberts MS, Benson HAE. Systemic absorption of sunscreen after topical application. Lancet 1997;350:863-4.
43. Revuz J, Marks R, Marguery MC, Pallardy M, Grosshans E, Machet L, Vaillant L, Beani JC, Jaillon P. Les anti-solaires doivent-ils être évalués comme des médicaments ? Ann Dermatol Venereol 1998;125:370-3.
44. Tan MH, Commens CA, Burnett L, Snitch PJ. A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australas J Dermatol 1996;37:185-7.
45. Dunford R, Salinaro A, Cai L, Serpone N, Horikoshi S, Hidaka H, Knowland J. Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients. FEBS Letters 1997; 418:87-90.
46. Dussert AS, Gooris E. Characterization of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum. Int J Cosmetic Sci 1997;19:119-29.
47. 3 synthesis. J Clin Endocrinol Metab 1987;64:1165-8.
48. Diffey BL. Sun protection : have we gone too far ? Br J Dermatol 1998;138:544-64.
49. Sutherland JC, Griffin KP. P-aminobenzoic acid can sensitize the formation of pyrimidine dimers in DNA : direct chemical evidence. Photochem Photobiol 1984;40:391-4.
50. Diffey BL, Grice J. The influence of sunscreen type on photoprotection. Br J Dermatol 1997; 137:103-5.
51. Bech-Thomsen N, Wulf HC. Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol Photoimmunol Photomed 1992/1993;9:242-4.
52. Diffey BL. People do not apply enough sunscreen for protection. Br Med J 1996;313:942.
53. Stokes R, Diffey B. How well are sunscreen users protected ? Photodermatol Photoimmunol Photomed 1997;13:186-8.
54. Wulf HC, Stender IM, Lock-Andersen J. Sunscreens used at the beach do not protect against erythema : a new definition of SPF is proposed. Photodermatol Photoimmunol Photomed 1997;13:129-32.
55. Garland CF, Garland FC, Gorham ED. Could sunscreens increase melanoma risk ? Am J Public Health 1992;82:814-5.
56. Autier P, Doré JF, Cattaruzza MS, Renard F, Luther H, Gentiloni-Silverj F, et al. Sunscreens use, wearing clothes, and number of nevi in 6-to 7-year-old european children. J Natl Cancer Inst 1998;90:1873-80.
57. Moyal D, Césarini JP, Binet O, Hourseau C. Reproduction « in door »de la lucite estivale bénigne. Mise en évidence de l'efficacité d'une crème possédant un fort pouvoir protecteur en UVA. Nouv Dermatol 1992;11:349-52.
58. Stege H, Ahrens C, Billmann-Eberwein C, Ruzicka T, Richard A, Rougier A, Krutmann J. Pretreatment of human skin with a sunscreen or dihydroxy-acetone (DHA) prevents photoprovocation-induced polymorphous light eruption (PLE) and keratinocyte (KC) ICAM-I expression. In : Rougier A, Schaefer H, eds. Protection of the skin against ultraviolet radiations. Paris : John Libbey Eurotext, 1998:207-11.
59. Peyron JL, Raison-Peyron N, Meynadier J, Moyal D, Rougier A, Hourseau C. Prevention of solar urticaria using a broadspectrum sunscreen and determination of a solar urticaria protection factor (SUPF). In : Rougier A, Schaefer H, eds : Protection of the skin against ultraviolet radiations, Paris : John Libbey Eurotext, 1998:201-5.
60. Grosshans E. Etudes contro̊lées des photoprotecteurs externes en pathologie cutanée. Ann Dermatol Venereol 1994;121:512-4.